Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2024, FY2025, FY2026). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $55.89 today, the market must believe free cash flow compounds 10.3%/yr for a decade (off $7.3M on the 3-yr avg basis).
The market's 10.3% is more conservative than its 7-yr track record.
Default is 9.9% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.00B shares (market data) · net debt -$905K
mean 62.5% · volatility σ 139% · implied rate exceeded in 3/7 yrs
Central path = implied 10.3%/yr growth; shaded band = ±1σ (139%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $1.3M buybacks = $1.3M returned on $4.9M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 12%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2026
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.6M 100.0% | $46.3M 100.0% | $44.6M 100.0% | $40.2M 100.0% | $30.9M 100.0% | $22.5M 100.0% | $28.4M 100.0% | $33.6M 100.0% | $24.4M 100.0% | $25.5M 100.0% |
| Cost of Revenue | $23.3M 55.9% | $24.8M 53.6% | $23.7M 53.3% | $23.3M 57.8% | $21.2M 68.8% | $19.3M 85.9% | $19.1M 67.5% | $24.6M 73.1% | $18.4M 75.7% | $17.6M 68.7% |
| Cost of Products | — | — | — | — | — | — | — | — | — | $17.6M 68.7% |
| Gross Profit | $18.3M 44.1% | $21.5M 46.4% | $20.8M 46.7% | $16.9M 42.2% | $9.6M 31.2% | $3.2M 14.1% | $9.2M 32.5% | $9.0M 26.9% | $5.9M 24.3% | $8.0M 31.3% |
| Research & Development | $776K 1.9% | $444K 1.0% | $388K 0.9% | $1.1M 2.7% | $999K 3.2% | $924K 4.1% | $585K 2.1% | $319K 0.9% | $263K 1.1% | $903K 3.5% |
| Selling, General & Admin | $10.2M 24.6% | $11.4M 24.6% | $11.0M 24.6% | $9.0M 22.5% | $6.2M 19.9% | $5.5M 24.6% | $5.9M 20.9% | $6.0M 18.0% | $5.3M 21.7% | $5.1M 19.8% |
| Operating Income | $7.3M 17.6% | $9.6M 20.8% | $9.5M 21.3% | $6.8M 16.9% | $2.5M 8.0% | -$2.4M -10.4% | $3.3M 11.6% | $3.0M 8.9% | $648K 2.7% | $2.9M 11.4% |
| Interest & Investment Income | $1.6M 3.9% | $1.4M 3.0% | $1.4M 3.2% | $699K 1.7% | $5K 0.0% | — | — | — | — | — |
| Other Income (Expense), net | $1.6M 4.0% | $1.4M 3.0% | $1.4M 3.2% | $696K 1.7% | $84K 0.3% | $3.0M 13.5% | $113K 0.4% | $58K 0.2% | $29K 0.1% | $67K 0.3% |
| Pretax Income | $9.0M 21.6% | $11.0M 23.8% | $10.9M 24.5% | $7.5M 18.7% | $2.6M 8.3% | $682K 3.0% | $3.4M 12.0% | $3.1M 9.1% | $676K 2.8% | $3.0M 11.7% |
| Income Tax Expense | $425K 1.0% | $1.6M 3.5% | $1.9M 4.3% | $1.2M 3.0% | $317K 1.0% | -$381K -1.7% | $386K 1.4% | $515K 1.5% | $233K 1.0% | $657K 2.6% |
| Net Income | $8.6M 20.6% | $9.4M 20.3% | $9.0M 20.2% | $6.3M 15.6% | $2.2M 7.3% | $1.1M 4.7% | $3.0M 10.7% | $2.5M 7.6% | $443K 1.8% | $2.3M 9.1% |
| Per Share | ||||||||||
| EPS (Basic) | $2.70 | $3.01 | $2.68 | $1.79 | $0.64 | $0.30 | — | — | $0.13 | $0.68 |
| EPS (Diluted) | $2.62 | $2.87 | $2.58 | $1.77 | $0.64 | — | — | — | $0.13 | $0.66 |
| Weighted Avg Shares (Basic) | — | — | — | — | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | 3.4M |
| Weighted Avg Shares (Diluted) | — | — | — | — | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 13 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 26 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ITW | $80.1B | 26.8× | 19.5× | 5.0× | 0.9% | 52.9% | 19.1% | 95.0% | 25.1% | 1.8× | 665 |
| IR | $31.0B | 55.2× | 20.9× | 4.1× | 5.7% | 43.6% | 7.6% | 5.8% | 3.9% | 2.1× | 243 |
| XYL | $20.8B | 23.1× | 11.8× | 2.3× | 5.5% | 38.5% | 10.6% | 8.3% | 7.1% | 0.3× | 285 |
| NDSN | $18.3B | 38.7× | 25.6× | 6.6× | 3.8% | 55.2% | 17.4% | 15.9% | 9.6% | 2.4× | 215 |
| ITT | $18.2B | 33.1× | 20.8× | 4.6× | 8.5% | 35.4% | 12.4% | 11.9% | 10.0% | -1.2× | 180 |
| ZBRA | $17.9B | 46.1× | 26.2× | 3.3× | 8.3% | 48.1% | 7.8% | 11.7% | 6.9% | 3.1× | 191 |
| IEX | $17.6B | 37.3× | 24.4× | 5.1× | 5.8% | 44.5% | 14.0% | 12.0% | 8.3% | 1.6× | 172 |
| HSAI | $16.3B | 30.2× | — | 37.7× | 52.1% | 41.8% | 14.4% | 4.9% | 4.5% | -3.2× | 21 |
| RBC | $15.7B | 54.5× | 35.2× | 8.4× | 14.3% | 44.4% | 15.4% | 8.6% | 6.8% | 1.8× | 131 |
| GGG | $11.0B | 22.3× | 14.2× | 4.9× | 5.8% | 52.5% | 23.3% | 19.7% | 19.7% | -0.8× | 177 |
| RRX | $10.9B | 39.0× | 18.1× | 1.8× | -1.6% | 37.4% | 4.7% | 4.1% | 2.4% | 5.1× | 131 |
| FLS | $10.2B | 30.4× | 22.3× | 2.2× | 3.8% | 33.4% | 7.3% | 15.8% | 9.2% | 1.6× | 132 |
| DCI | $9.9B | 22.1× | 15.5× | 2.5× | 5.3% | 34.6% | 11.7% | 25.7% | 14.7% | 1.5× | 163 |
| TKR | $8.0B | 27.9× | 12.3× | 1.7× | 0.2% | 30.4% | 6.3% | 9.1% | 5.7% | 2.0× | 146 |
| ZWS | $7.4B | 38.9× | 24.5× | 4.3× | 8.3% | 45.1% | 11.7% | 12.3% | 9.4% | 0.6× | 90 |
| GTES | $6.6B | 27.3× | 11.9× | 1.9× | 1.0% | 39.8% | 7.3% | 7.5% | 4.5% | 2.1× | 1 |
| ESAB | $4.6B | 20.2× | 11.4× | 1.6× | 3.7% | 36.9% | 8.0% | 10.5% | 6.7% | 2.1× | 72 |
| CECO | $3.2B | 39.9× | 25.9× | 4.1× | 38.8% | 34.8% | 6.5% | 15.8% | 9.4% | 1.4× | 60 |
| OUST | $2.3B | — | — | 13.7× | 52.5% | 49.3% | -35.6% | -23.1% | -23.1% | — | 63 |
| CHRN | $2.3B | — | 99.3× | 31.8× | 459% | -23.9% | -70.3% | -28.0% | -27.4% | -0.3× | — |
| GRC | $2.0B | 36.8× | 18.2× | 2.9× | 3.4% | 30.6% | 7.8% | 12.8% | 7.3% | 2.2× | 51 |
| GHM | $841M | 64.0× | 41.7× | 3.4× | 16.9% | 23.5% | 5.1% | 8.9% | 8.2% | 0.3× | 35 |
| TWIN | $368M | 13.6× | 12.0× | 1.0× | 11.9% | 26.9% | 7.1% | 12.3% | 10.9% | 0.4× | 14 |
| HLP | $313M | 139.7× | 103.5× | 16.0× | — | 32.5% | 9.9% | 3.4% | 2.8% | 3.1× | 1 |
| PPIH | $246M | 14.3× | 7.5× | 1.2× | 33.2% | 32.9% | 8.1% | 18.8% | 13.8% | 0.4× | 19 |
| TAYD | $184M | 21.7× | 19.8× | 4.4× | -10.0% | 44.1% | 20.6% | 11.8% | 11.8% | -0.1× | 11 |
Peers = companies sharing TAYD's sector (General Industrial Machinery & Equipment, NEC) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-02 | 2 co-filers Group filing | Option exercise | 5,000 | $13.80 | $69k |
| 2026-10-02 | 2 co-filers Group filing | Option exercise | 5,000 | $0.00 | — |
| 2026-04-28 | 2 co-filers Group filing | Open-market sale | 3,445 | $57.27 | $197k |
| 2026-04-28 | 2 co-filers Group filing | Open-market sale | 1,555 | $55.52 | $86k |
| 2026-04-18 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Grant |
| 7,000 |
| $0.00 |
| — |
| 2026-04-18 | Carey Robert Michael Director | Grant | 7,000 | $0.00 | — |
| 2026-04-18 | Heary Paul Murray Chief Financial Officer | Grant | 7,000 | $0.00 | — |
| 2026-04-18 | Burgess John Director | Grant | 7,000 | $0.00 | — |
| 2026-04-18 | Armenat Fritz Eric Director | Grant | 7,000 | $0.00 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 5,000 | $16.40 | $82k |
| 2026-04-13 | 3 co-filers Group filing | Tax withholding | 1,574 | $52.11 | $82k |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 5,000 | $0.00 | — |
| 2026-01-23 | 4 co-filers Group filing | Open-market sale | 528 | $72.10 | $38k |
| 2026-01-23 | 4 co-filers Group filing | Open-market sale | 300 | $71.19 | $21k |
| 2026-01-23 | 4 co-filers Group filing | Open-market sale | 700 | $72.85 | $51k |
| 2026-01-22 | 4 co-filers Group filing | Open-market sale | 2,800 | $71.77 | $201k |
| 2026-01-21 | 3 co-filers Group filing | Option exercise | 5,000 | $9.85 | $49k |
| 2026-01-21 | 3 co-filers Group filing | Tax withholding | 672 | $73.28 | $49k |
| 2026-01-21 | 3 co-filers Group filing | Option exercise | 5,000 | $0.00 | — |
| 2026-01-14 | 2 co-filers Group filing | Open-market sale | 3,820 | $73.21 | $280k |
| 2026-01-14 | 2 co-filers Group filing | Open-market sale | 300 | $74.00 | $22k |
| 2026-01-09 | 3 co-filers Group filing | Option exercise | 5,000 | $11.97 | $60k |
| 2026-01-09 | 3 co-filers Group filing | Tax withholding | 880 | $68.06 | $60k |
| 2026-01-09 | 3 co-filers Group filing | Option exercise | 5,000 | $0.00 | — |
EOD close · as of 2026-10-30
Where each multiple sits in its own 15-yr range · 88th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
ROE 12% against ROIC 12% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.4× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 73.1 | 67.5 | 85.9 | 68.8 | 57.8 | 53.3 | 53.6 | 55.9 |
| Gross Profit | 26.9 | 32.5 | 14.1 | 31.2 | 42.2 | 46.7 | 46.4 | 44.1 |
| R&D | 0.9 | 2.1 | 4.1 | 3.2 | 2.7 | 0.9 | 1.0 | 1.9 |
| SG&A | 18.0 | 20.9 | 24.6 | 19.9 | 22.5 | 24.6 | 24.6 | 24.6 |
| Operating Income | 8.9 | 11.6 | -10.4 | 8.0 | 16.9 | 21.3 | 20.8 | 17.6 |
| Income Tax | 1.5 | 1.4 | -1.7 | 1.0 | 3.0 | 4.3 | 3.5 | 1.0 |
| Net Income | 7.6 | 10.7 | 4.7 | 7.3 | 15.6 | 20.2 | 20.3 | 20.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TAYD: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -0.43pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2020 | 11.6% | 9.9% (today's — no rate published for this year) | 1.7pts |
| FY2021 | -10.0% | 9.9% (today's — no rate published for this year) | -19.9pts |
| FY2022 | 10.2% | 9.1% | 1.1pts |
| FY2023 | 12.6% | 8.4% | 4.2pts |
| FY2024 | 16.9% | 9.3% | 7.5pts |
| FY2025 | 13.7% | 10.7% | 2.9pts |
| FY2026 | 8.8% | 11.1% | -2.3pts |
| Now | 11.8% | 9.9% | 1.9pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2017 | 31.3% | 11.4% | 9.1% |
| FY2018 | 24.3% | 2.7% | 1.8% |
| FY2019 | 26.9% | 8.9% | 7.6% |
| FY2020 | 32.5% | 11.6% | 10.7% |
| FY2021 | 14.1% | -10.4% | 4.7% |
| FY2022 | 31.2% | 8.0% | 7.3% |
| FY2023 | 42.2% | 16.9% | 15.6% |
| FY2024 | 46.7% | 21.3% | 20.2% |
| FY2025 | 46.4% | 20.8% | 20.3% |
| FY2026 | 44.1% | 17.6% | 20.6% |
Return on equity (12%) and return on invested capital (12%) are within a couple of points in FY2026, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
The spread is -0.43pts and would invert under a ±2% move in WACC, so the verdict rests on the cost-of-capital assumption rather than on the business.
Converts 0.80x of reported profit into cash — adequate, without much margin.
Shares outstanding are up 23% since FY2020 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Missing from our data, so excluded from this answer: share_based_compensation.
No debt, so there is no leverage path to distress.
Balance sheet at 2026-05-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
At $56.87, free cash flow must compound 10.56%/yr for 10 years. It has done -8.99%/yr over 6 years, though across a reporting-basis change.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | −37.1% | 10.6% |
| FY2022 | −64.6% | 10.6% |
| FY2023 | 126.8% | 10.6% |
| FY2024 | 177.6% | 10.6% |
| FY2025 | −59.7% | 10.6% |
| FY2026 | 0.3% | 10.6% |
The achieved growth rate spans a reporting-basis change in FY2022, so part of it measures the restatement rather than the business.
| Step | Amount | Running total |
|---|---|---|
| Net income | $9M | $9M |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | −$2M | $7M |
| Operating cash flow | $7M | $7M |
| Capex | −$2M | $5M |
| Free cash flow | $5M | $5M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2021 | -20.7% | -29.2% | -8.5 points |
| FY2022 | 37.1% | 8.4% | -28.7 points |
| FY2023 | 30.2% | not reported | not reported |
| FY2024 | 10.9% | not reported | not reported |
| FY2025 | 3.8% | not reported | not reported |
| FY2026 | -10.0% | not reported | not reported |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2020 | 74.8 days | 192.7 days | 26.1 days | 241.4 days |
| FY2021 | 66.8 days | 110.2 days | 33.7 days | 143.2 days |
| FY2022 | 52.8 days | 100.6 days | 24.5 days | 128.9 days |
| FY2023 | not reported | 93.3 days | 27 days | not reported |
| FY2024 | not reported | 115.5 days | 22.1 days | not reported |
| FY2025 | not reported | 119.3 days | 16.5 days | not reported |
| FY2026 | 34.5 days | 117.9 days | 9 days | 143.4 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2020 | -15.1 percent |
| FY2021 | -13.0 percent |
| FY2022 | -2.2 percent |
| FY2023 | -2.5 percent |
| FY2024 | -6.7 percent |
| FY2025 | 2.7 percent |
| FY2026 | 2.0 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.